Throughout the month of October our team will be continuously curating and publishing timely, informative articles about breast cancer and advances in breast cancer treatment. We hope you enjoy this resource!
October 4, 2019 (HealthDay News) The addition of abemaciclib to fulvestrant provides a statistically significant and clinically meaningful gain in median overall survival, regardless of menopausal status, for women with... Read More
April 30, 2019 (Journal of the Endocrine Society) This case-series study aimed to uncover possible genetic mutations that may predispose patients with Neuroendocrine tumors (NET) to later develop breast cancer.... Read More
September 3, 2019 (Medical News Today) Recent studies have gone deeper into understanding why breast cancer may reoccur in some patients after treatment. A study appearing in the journal Nature... Read More
February 20, 2019 (Drugs.com) An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the... Read More